In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers have identified two tiny bits of non-coding genetic material in primary tumors that appear critical to stalling the cancer’s spread — and essentially setting the biological fate of the disease.